Gary T. Elliott
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Gary T. Elliott
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.
12
| Subsidiary | Biotechnology | 12 |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Salmedix, Inc. develops oncology and small molecule drugs to treat hematological malignancies. The company's product, Treanda, is currently in Phase II clinical trials in the United States and Canada for the treatment of indolent (slowly progressing) non-Hodgkin's lymphoma. It was founded in 2000 and is located in San Diego, CA.
9
| Extinct | Pharmaceuticals: Major | 9 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gary T. Elliott via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Corporate Officer/Principal | |
| Yale University | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Graduate Degree | |
| Baylor College of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree | |
| PDL BIOPHARMA, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of California, Santa Barbara | College/University | Undergraduate Degree Undergraduate Degree | |
| CHEMOCENTRYX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
| MORPHOSYS AG | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Drexel University College of Medicine | College/University | Graduate Degree | |
| Mutual of New York Life /2 Hampton Inns/ | Hotels/Resorts/Cruise lines | Corporate Officer/Principal | |
Gemini Advisors
 Gemini Advisors Miscellaneous Commercial ServicesCommercial Services Gemini Advisors provides business development and strategic advisory consultancy services. The private company is based in San Diego, CA. The CEO of the company is Wendy S. Johnson. | Miscellaneous Commercial Services | Chief Executive Officer | |
| RENEO PHARMACEUTICALS, INC. | Biotechnology | Corporate Officer/Principal | |
| Center for Devices & Radiological Health | General Government | Corporate Officer/Principal | |
| INTERMUNE INC | Biotechnology | Director/Board Member | |
| Loyola Marymount University | College/University | Masters Business Admin | |
| EXAGEN INC. | Medical/Nursing Services | Director/Board Member | |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | General Government | Corporate Officer/Principal | |
Trialspark, Inc.
 Trialspark, Inc. Investment ManagersFinance Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US. | Investment Managers | Consultant / Advisor | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor | |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Tranzyme Pharma, Inc. (Canada) | Director/Board Member | ||
| McGill University | College/University | Undergraduate Degree | |
H.I.G. BioHealth Partners LLC
 H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Investment Managers | Private Equity Investor | |
Intact Vascular, Inc.
 Intact Vascular, Inc. Medical SpecialtiesHealth Technology Intact Vascular, Inc. develops products for minimally invasive peripheral vascular procedures. Its tack endovascular system is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease and this technology will offer physicians a new treatment option for treating peripheral artery disease. The company was founded by Robert Mero Giasolli and Peter M. Schneider in 2011 and is headquartered in Wayne, PA. | Medical Specialties | Director/Board Member | |
H.I.G. Capital LLC
 H.I.G. Capital LLC Financial ConglomeratesFinance H.I.G. Capital LLC operates as s a private equity and alternative assets investment firm. Its portfolio focuses in private equity, growth equity, real estate, debt or credit, lending, and bio health. The company was founded by Sami W. Mnaymneh and Anthony Tamer in 1993 and is headquartered in Miami, FL. | Financial Conglomerates | Corporate Officer/Principal | |
Cardeas Pharma Corp.
 Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
HyperBranch Medical Technology, Inc.
 HyperBranch Medical Technology, Inc. Medical SpecialtiesHealth Technology HyperBranch Medical Technology, Inc. develops and markets biosurgical devices. It develops and markets products primarily for the traumatic or surgically induced wound market. The firm offers Adherus AutoSpray Dural Sealant which is a synthetic, absorbable, two-component dural sealant indicated for use in patients as an adjunct to standard methods of dural repair. The company was founded by Mark W. Grinstaff and Anthony J. Sherbondy in March 2003 and is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
| Murex Corp. | Corporate Officer/Principal | ||
Theraclone Sciences, Inc.
 Theraclone Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Theraclone Sciences, Inc. develops novel therapeutic antibodies for the treatment of cancer and infectious diseases. The firm leverages its proprietary antibody discovery technology, I-STARTM to identify rare fully human antibodies from immunologically relevant human subjects. The firm’s primary research focus is to discover novel targets and antibodies, and develop therapeutic monoclonal antibodies, by using its proprietary B-cell technology platform to mine the immune system of cancer patients. The company was founded by Johnny T. Stine in November 2004 and is headquartered in Seattle, WA. | Miscellaneous Commercial Services | President | |
| New York University | College/University | Doctorate Degree | |
| The Johns Hopkins University | College/University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 46 |
| Canada | 5 |
| Duitsland | 2 |
Sectoraal
| Health Technology | 23 |
| Consumer Services | 15 |
| Finance | 7 |
| Commercial Services | 3 |
| Government | 3 |
Operationeel
| Director/Board Member | 116 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 35 |
| Chief Tech/Sci/R&D Officer | 30 |
| Undergraduate Degree | 22 |
Sterkste connecties
| Insiders | |
|---|---|
| Mark McDade | 35 |
| David Kabakoff | 30 |
| Karin Eastham | 29 |
| Samuel Saks | 28 |
| Aaron Davidson | 24 |
| Wendy Johnson | 23 |
| Sam Wertheimer | 17 |
| Pratik Multani | 16 |
| Robert Hershberg | 16 |
| Don Soland | 14 |
| Shawn A. Scranton | 10 |
| Ethel M. Koczon | 9 |
| Stanford J. Stewart | 9 |
| Noel Howe | 9 |
| David Fanning | 8 |
- Beurs
- Insiders
- Gary T. Elliott
- Bedrijfsconnecties
